免疫检查点抑制早期三阴性乳腺癌的进展
Ahmed Mohamed1, Megan Kruse1, Jennifer Tran1
1Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, United States of America.
Expert review of anticancer therapy
|September 25, 2023
概括
新辅助免疫疗法与化疗相结合,改善了早期三阴性乳腺癌 (TNBC) 的结果. 研究探讨了优化这种方法及其辅助用途,以更好地治疗乳腺癌.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- 免疫检查点抑制剂在转移性ER阴性,HER2阴性乳腺癌中显示出有效性.
- 早期的三阴性乳腺癌 (TNBC) 具有不理想的结果和有限的选择,促使免疫疗法调查.
研究的目的:
- 审查新辅助免疫疗法与早期TNBC的化疗.
- 探索辅助检查点抑制和新型免疫疗法组合.
主要方法:
- 对新辅助免疫疗法和化学疗法在早期TNBC的研究进行审查.
- 对正在进行的辅助疗法和组合治疗研究进行分析.
主要成果:
- 新辅助药 pembrolizumab与化疗是特定早期TNBC的标准,改善PCR和无事件存活率.
- 无论PD-L1状态如何,都观察到有效性.
结论:
- 需要进一步的研究来优化化疗合作伙伴的免疫治疗.
- 关于辅助免疫治疗的必要性和最佳使用的问题仍然存在,特别是与其他药物 (如capecitabine或olaparib) 结合使用.
相关概念视频
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


